White Plains, NY, United States of America

Mujahid L Shaikh

This inventor holds 2 USPTO granted patents. Top assignee: Usv Pharmaceutical Corporation. Active years: 1985-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mujahid L Shaikh. Retrieved from https://idiyas.com/inventor/mujahid-l-shaikh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1985-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mujahid L Shaikh

Introduction

Mujahid L Shaikh is a notable inventor based in White Plains, NY (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on developing novel compounds that have potential therapeutic applications.

Latest Patents

Mujahid's latest patents include innovative pharmaceutical compounds. One of his patents involves bisbenzothiazine, bisbenzodiazine, and bisquinoline compounds, characterized by the formula: ##STR1##, where R can be H, alkyl, cycloalkyl, aryl, or heteroaryl. Another patent pertains to bisbenzoxazines and their pharmaceutical uses, defined by the formula: ##STR1##, with R also representing H, alkyl, cycloalkyl, aryl, or heteroaryl.

Career Highlights

Mujahid L Shaikh is currently associated with USV Pharmaceutical Corporation, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Mujahid has collaborated with esteemed colleagues, including Howard Jones and Ernest Magnien, enhancing the scope and impact of his research.

Conclusion

Mujahid L Shaikh's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a dedication to developing new therapeutic compounds that could benefit many.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…